Case study: Paperless QC Micro Implemented by Talecris Biotherapeutics

Published: 27-Oct-2011

Paper-based processes still burden most QC micro programs with paper scheduling, lab marker labeling of sample media, manual reconciliation, paper log book entry, and manual notification on deviations. These steps are labor-intensive, time consuming, and yield duplication of tasks and high error rates. Talecris, a global biotherapeutic and biotechnology company that discovers, develops, and produces biotherapeutics for people with life-threatening disorders, successfully implemented MODA™—a paperless QC micro solution by Lonza. As a result, Talecris was able to automate their QC process for improved environmental monitoring (EM), utility testing, and product testing.


Featured speaker
Marvin Thompson, Manager, Quality Operations, Talecris Biotherapeutics

Focus areas:
• Paperless QC process and the MODA™ solution
• Scope of the Talecris QC micro program
• Previous processes and the need for automation
• Key requirements for new solution and selection process of MODA™
• Implementation and validation of current state and plans for the future


Click here to download the webinar PDF presentation and video recording (From May 11, 2010)
*Note: Log in is required to access Lonza’s webinar archives. If you do not have a Lonza account, sign up by filing out a short form. This account will also give you access to Lonza’s comprehensive Cell Transfection Database.

  • Companies:
  • Lonza
See more

You may also like

Regulatory

UPDATE: US Pharmacopeia makes comments public on endotoxin testing overhaul

Read more
The USP has published the comments the organisation received in response to the addition of non-animal derived endotoxin testing methods, as well as an FAQ page on the issue

Trending Articles

  1. CAR T-cell therapy: contamination control & role of PPE CAR T-cell therapy, an innovative approach to treating certain types of cancer, relies on the genetic modification of a patient's immune cells to target and destroy cancer cells. This complex process requires highly specialised laboratory procedures, and it is essential to prioritise the safety of the modified cells, the patient, and the healthcare professionals involved
  2. Guardtech Group hoping to end golden year with more success at SME National Business Awards Suffolk contamination control experts looking to add Best Enterprising Business prize to epic 2024 awards haul at glitzy Wembley Stadium showpiece on 6 December
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    What is ISO 8 cleanroom classification? Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
  4. Symbiosis acquires a 20,000 sq/ft building financed by Barclays Corporate Bank Symbiosis acquires a 20,000 sq/ft building in Stirling, UK, to house new high-tech medicines manufacturing capacity, financed by £1.2m from Barclays Corporate Bank PLC
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Integrity testing of HEPA filters: A practical approach Filtering the air in aseptic process areas is critical to maintaining the cleanliness of the production environment. Jesus Casas provides tips to ensure HEPA filters are fit for purpose once installed in your facility

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Regulatory

UPDATE: US Pharmacopeia makes comments public on endotoxin testing overhaul

The USP has published the comments the organisation received in response to the addition of non-animal derived endotoxin testing methods, as well as an FAQ page on the issue
Cleaning

Lonza expands PyroCell pyrogen testing portfolio with two new rapid systems

Lonza has launched PyroCell MAT Rapid System and PyroCellMAT Human Serum (HS) Rapid System, two sustainable monocyte activation test (MAT) systems containing the new PeliKine Human IL-6 Rapid ELISA Kit
Analysis

Lonza to phase out traditional endotoxin testing LAL and TAL assay reader for new tech

The company has launched the Nebula Absorbance Reader that is a technologically advanced, high-performance replacement reader, which delivers results comparable to those typically found with the traditional method and will facilitate the smooth continuation of current pyrogen and endotoxin testing programmes
Pharmaceutical

Q&A: Lonza’s PyroCell Monocyte activation test

Lonza has launched the PyroCell MAT that uses human serum instead of foetal bovine serum for pharmaceutical testing, but how does it change the status quo?
Design & Build

Lonza commissions BAM for Chemelot mRNA facility renovation

Lonza has commissioned BAM to renovate the ground floor up to and including the second floor of its Brighthouse building 300 on the Brightlands Chemelot Campus
Cleaning

Q&A on Lonza’s new PyroCell Monocyte Activation Test

Speaking to Katrin Pauls from Lonza about the launch of the company's PyroCell MAT, which uses human serum instead of foetal bovine serum for pharmaceutical testing, and how it changes the status quo
Cleaning

Lonza debuts first multimode reader to streamline quantitative endotoxin detection

The global science company has launched the Nebula Multimode Reader, the first multimode reader qualified for use with Lonza’s turbidimetric, chromogenic and recombinant endotoxin detection methods
Subscribe now